1. Home
  2. GAUZ vs PBYI Comparison

GAUZ vs PBYI Comparison

Compare GAUZ & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gauzy Ltd. Ordinary Shares

GAUZ

Gauzy Ltd. Ordinary Shares

HOLD

Current Price

$1.06

Market Cap

102.0M

Sector

Miscellaneous

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$5.83

Market Cap

263.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAUZ
PBYI
Founded
2009
2010
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.0M
263.4M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
GAUZ
PBYI
Price
$1.06
$5.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$11.50
$7.00
AVG Volume (30 Days)
327.3K
398.8K
Earning Date
03-11-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.87
EPS
N/A
0.74
Revenue
$96,810,000.00
$211,995,000.00
Revenue This Year
$22.59
N/A
Revenue Next Year
$47.83
N/A
P/E Ratio
N/A
$7.56
Revenue Growth
7.87
N/A
52 Week Low
$0.95
$2.58
52 Week High
$13.00
$6.12

Technical Indicators

Market Signals
Indicator
GAUZ
PBYI
Relative Strength Index (RSI) 28.61 63.95
Support Level $0.95 $5.51
Resistance Level $1.57 $5.73
Average True Range (ATR) 0.27 0.23
MACD 0.09 0.03
Stochastic Oscillator 6.69 93.15

Price Performance

Historical Comparison
GAUZ
PBYI

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: